Gustaf Wiklund

Associate, Stockholm

Biography

Overview

Gustaf Wiklund is an associate in our Capital Markets practice in Stockholm.

Gustaf has significant experience from advising domestic and international issuers, owners, sponsors and underwriters on a variety of capital markets transactions, including IPOs, rights issues, ABBs and private placements, as well as public M&A transactions, such as international buy-outs. He also advises several listed companies on various corporate governance related matters, including in relation to general meetings and compliance.

Bars and Courts
Swedish Bar
Education
LLM
Master of Laws
Gothenburg School of Business
Economics and Law, Sweden
Languages
Swedish
English

Experience

Representation of Oatly in connection with its USD 10 billion initial public offering (IPO) and New York listing on the Nasdaq Global Select Market.

Representation of Carnegie Investment Bank, a financial services group, as sole global coordinator and joint bookrunner and Swedbank, a Nordic-Baltic banking group, as joint bookrunner in connection with the EUR 64 million IPO and Nasdaq Helsinki listing of Optomed, a health care technology company.

Representation of Karo Pharma, a company that specializes in the sale and marketing of prescription pharmaceuticals and over-the-counter products, in connection with its fully underwritten SEK 2.0 billion rights issue.

Representation of Jefferies, Carnegie, DNB, Cowen and Kempen, all financial services firms, as the joint global coordinators and placement agents in connection with the SEK 727 million private placement of shares in Oncopeptides, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat haematological diseases.

Representation of Carnegie and Nordea, both financial services groups, in connection with the SEK 4.2 billion IPO and Nasdaq Stockholm listing of Karnov Group, a provider of information and advisory.

Representation of Bridgepoint, a private equity firm, and European Entertainment Intressenter BidCo AB, an investment firm, on the SEK 9.2 billion public cash offer to the shareholders of Cherry, one of Scandinavia’s oldest gaming companies.

Representation of EQT, a leading global investment firm, on 

  • the SEK 6.2 billion public cash offer to the shareholders of Karo Pharma, a company that specializes in the sale and marketing of prescription pharmaceuticals and over-the-counter products.
  • their dual track exit of Piab, a leader in industrial vacuum-based automation and robot components, resulting in the sale to Investor AB (publ) (Patricia Industries) for an enterprise value of SEK 7.0 billion.

Representation of Jefferies, Carnegie and DNB, all financial services firms, as the joint bookrunners and placement agents in connection with the SEK 546 million private placement of shares in Oncopeptides, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat haematological diseases.

Representation of Deutsche Bank and Nordea, both financial services firms, as the joint bookrunners and placement agents in connection with the SEK 568 million private placement of shares in Hoist Finance, a Swedish financial services company.

Representation of Arion Banki, a leading universal relationship bank in Iceland, and Kaupthing, an Icelandic bank, in connection with the SEK 3.2 billion IPO and dual-listing in Stockholm and Reykjavik of Arion Bank.

Representation of Projektengagemang, a civil engineering consulting firm, and its founders in connection with the 470 million IPO and Nasdaq Stockholm listing of Projektengagemang.

Representation of Ovzon, a broadband telecommunication company offering mobile communication services via satellite, and its founders in connection with the SEK 325 million IPO and Nasdaq First North Premier listing of Ovzon.

Representation of DNB, Swedbank and Crédit Agricole, all financial services firms, as placement agents in connection with the SEK 508 million private placement of shares in Recipharm, a pharmaceutical contract development and manufacturing organisation.

Representation of Handicare, a leading manufacturer of solutions and medical equipment for disabled and elderly people, and its principal shareholder Nordic Capital, a leading private equity firm in the Nordic region, in connection with the SEK 854.6 million IPO and Nasdaq Stockholm listing of Handicare.

Representation of Carnegie, Goldman Sachs, Danske Bank, Jefferies, Nordea, and Swedbank, all financial services firms, as underwriters in connection with the SEK 4.0 billion IPO and Nasdaq Stockholm listing of Munters, a global provider of energy efficient air treatment systems.

Representation of Carnegie, Danske Bank and Berenberg, both financial services institutions, as underwriters in connection with the SEK 1.6 billion IPO and Nasdaq Stockholm listing of Boozt, a leading on-line retailer.

Representation of ABG Sundal Collier, Carnegie and DNB, all financial services institutions, as underwriters in connection with the SEK 650 million IPO and Nasdaq Stockholm listing of Oncopeptides, a research and development stage pharmaceutical company developing drugs for treat of cancer.